TDS Pharm Co (XKRX:464280) Total Liabilities : ₩11,025 Mil (As of Dec. 2023)

View and export this data going back to 2024. Start your Free Trial

What is TDS Pharm Co Total Liabilities?

TDS Pharm Co's Total Liabilities for the quarter that ended in Dec. 2023 was ₩11,025 Mil.

TDS Pharm Co's quarterly Total Liabilities increased from Dec. 2021 (₩10,824.43 Mil) to Dec. 2022 (₩12,160.16 Mil) but then declined from Dec. 2022 (₩12,160.16 Mil) to Dec. 2023 (₩11,025.47 Mil).

TDS Pharm Co's annual Total Liabilities increased from Dec. 2021 (₩10,824.43 Mil) to Dec. 2022 (₩12,160.16 Mil) but then declined from Dec. 2022 (₩12,160.16 Mil) to Dec. 2023 (₩11,025.47 Mil).

TDS Pharm Co Total Liabilities Historical Data

The historical data trend for TDS Pharm Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TDS Pharm Co Total Liabilities Chart

TDS Pharm Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Total Liabilities

10,258.69

10,824.43

12,160.16

11,025.47

TDS Pharm Co Semi-Annual Data
	Dec20	Dec21	Dec22	Dec23
Total Liabilities	10,258.69	10,824.43	12,160.16	11,025.47

TDS Pharm Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

TDS Pharm Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	10065.351	+	(869.7	+	-4.6895820560167E-13
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	90.414)
	=	11,025

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	33970.008	-	22944.543
	=	11,025

TDS Pharm Co's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	10065.351	+	(869.7	+	-4.6895820560167E-13
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	90.414)
	=	11,025

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	33970.008	-	22944.543
	=	11,025

TDS Pharm Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of TDS Pharm Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

TDS Pharm Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TDS Pharm Co Ltd (XKRX:464280) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

253 Pangyo-ro, Pangyo Inno Valley, Building C, Room 403, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13486

Website

https://www.tdspharm.com

TDS Pharm Co Ltd is engaged in the development and manufacturing of the Transdermal Drug Delivery System (TDDS), which is growing as a high-growth business sector in the field of drug delivery systems (DDS). The Transdermal Drug Delivery System (TDDS) is a drug delivery system that delivers drugs through the skin at a controlled speed. It has the advantages of increasing patient compliance with drugs, maximizing efficacy and effectiveness, such as minimizing side effects in the liver and digestive organs, controlling absorption rate, controlling discontinuation, controlling effective blood concentration, and enabling long-term continuous administration, and reducing burden compared to oral and injection drugs.

TDS Pharm Co Headlines

No Headlines